Evolent Health's Potential Sale Attracts Key Interest from Equity Firms and Health Insurers

Evolent Health is reportedly in discussions with private equity firms and healthcare service providers about a potential sale. Companies like TPG, CD&R, and KKR have shown interest, as well as health insurer Elevance Health. Evolent's shares surged on the news, despite previous market declines.

Evolent Health is reportedly engaging with private equity firms and healthcare service providers regarding a potential sale, following takeover interest, according to sources familiar with the situation.

Private equity firms TPG, CD&R, and KKR, along with health insurer Elevance Health, are among the interested parties. Evolent's shares soared over 18% upon the news, despite a earlier decrease since the beginning of the year.

The sale process, in collaboration with a financial adviser, received initial bids and may conclude within weeks, although sources cautioned that a deal isn't certain. Founded in 2011, Evolent provides software to help healthcare providers transition to value-based care models and has seen significant revenue growth amid fluctuating market expectations.

(With inputs from agencies.)